Expansion of Fresenius Kidney Care dialysis centre in Perak increases access to dialysis treatment for more Malaysians

FKC Logo Article Icon


Pusat Dialisis Taiping Parit Buntar is now Fresenius Kidney Care’s largest private dialysis centre in Malaysia

Fresenius Medical Care, the world’s largest provider of dialysis products and services, has announced the expansion and renovation of its Pusat Dialisis Taiping (PDT) Parit Buntar Fresenius Kidney Care dialysis centre. The expanded facility provides 29 dialysis stations that deliver life-saving dialysis treatment and is able to care for up to 174 patients, making it the company’s largest dialysis centre in Malaysia.

“With the number of people undergoing dialysis in Malaysia more than doubling over the last 10 years to reach almost 40,000 patients1, there is an urgent demand for clinics that are able to provide excellent care for more patients", said Mr Michael Wong, Managing Director, Fresenius Medical Care Malaysia. "The expanded centre provides patients with the high standards of technology, patient comfort and highly-qualified medical staff that Malaysia has come to expect from Fresenius Medical Care", he said.

PDT Parit Buntar dialysis centre provides high-flux haemodialysis that allows better removal of waste products from the blood which is a significant contributing factor for improved long-term results for dialysis patients.2

The centre’s expansion was officially celebrated on 24 September with a thanksgiving prayer, followed by a tour of the patient treatment areas and the water purification facility. The celebration was attended by government and local council representatives, senior members of the Fresenius Medical Care Malaysia and South Asia Pacific teams, as well as clinic patients and their family members.1

Fresenius Kidney Care Managing Director, Dr Thirunavakarasu Pathmanathan, emphasised the company's role in expanding the reach of dialysis care throughout the country: "In Malaysia, Fresenius Medical Care has been providing dialysis products and therapies for 18 years. Our dialysis treatment and services division, which has been newly named Fresenius Kidney Care, highlights our expertise in providing treatments and care that fit with our patients’ needs and allow them to lead more active and fulfilling lives. Our Fresenius Kidney Care PDT Parit Buntar centre, together with 16 other dialysis facilities across the country, means that we are now able to assist Malaysia in expanding the reach of dialysis care."

1 24th Report of the Malaysian Dialysis and Transplant Registry 2016. Chapter 1: All Renal Replacement Therapy In Malaysia. Available from https://www.msn.org.my/nrr/mdtr2016.jsp. Accessed 25 September 2018. 2 Tattersall J., et al., Nephrol Dial Transplant. (2007); 22 [Suppl 2]: ii5–ii21.

Fresenius Medical Care is the world's largest provider of products and services for individuals with renal diseases of which around 3.2 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,815 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 325,188 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the company provides related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).

For more information visit the Company’s website at www.freseniusmedicalcare.com

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Dr. Alexandra Villar
Senior Director Marketing Communications Asia Pacific
Fresenius Medical Care